ArticleCancers2024

The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma.

Sebastian Podlipnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.